Skip to content
1st Counsel – Lifestyle
Author:
Zealand Pharma
Zealand Pharma to participate in upcoming investor conferences in March 2026
March 9, 2026
Zealand Pharma announces positive Phase 2 results for petrelintide, an amylin analog with potential to redefine the weight management experience for people living with overweight and obesity
March 5, 2026
←
Previous Page
1
2
3
4